Sun Pharma Advanced Research Company Limited Share Price
Equities
SPARC
INE232I01014
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
217.4 INR | -0.91% | +3.40% | -24.20% |
Sales 2022 | 1.37B 16.44M | Sales 2023 | 2.39B 28.59M | Capitalization | 58.2B 697M |
---|---|---|---|---|---|
Net income 2022 | -2.03B -24.36M | Net income 2023 | -2.23B -26.66M | EV / Sales 2022 | 59.3 x |
Net Debt 2022 | 663M 7.94M | Net cash position 2023 | 3.87B 46.32M | EV / Sales 2023 | 22.8 x |
P/E ratio 2022 |
-38.4
x | P/E ratio 2023 |
-22.9
x | Employees | 407 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 25.38% |
Latest transcript on Sun Pharma Advanced Research Company Limited
1 day | -0.16% | ||
1 week | -0.57% | ||
Current month | -5.70% | ||
1 month | -43.52% | ||
3 months | -37.84% | ||
6 months | -13.20% | ||
Current year | -23.62% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 24/14/24 | |
Chetan Rajpara
DFI | Director of Finance/CFO | - | 01/17/01 |
Chairman | 68 | 01/06/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 68 | 01/06/01 | |
Director/Board Member | 67 | 01/06/01 | |
Director/Board Member | 70 | 31/14/31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.00% | 112 M€ | +4.91% | - | |
0.00% | 34 M€ | +3.53% | - |
Date | Price | Change | Volume |
---|---|---|---|
15/24/15 | 217.4 | -0.91% | 522 641 |
14/24/14 | 219.4 | +2.26% | 1,295,655 |
13/24/13 | 214.6 | -2.03% | 613,196 |
10/24/10 | 219 | +3.23% | 772,695 |
09/24/09 | 212.2 | -3.70% | 2,222,178 |
Delayed Quote NSE India S.E., May 15, 2024 at 12:48 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
-23.62% | 853M | |
+31.06% | 688B | |
+30.35% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+15.53% | 239B | |
+10.16% | 210B | |
-8.14% | 200B | |
+8.12% | 167B |
- Stock Market
- Equities
- SPARC Stock